Post-licensure experience with rotavirus vaccination in Latin America and the Caribbean: a systematic review and meta-analysis

References

• Troeger C, Khalil IA, Rao PC. Rotavirus vaccination and the global burden of rotavirus diarrhea among children younger than 5 years. JAMA Pediatr. 2018;172(10):958–965.
   PubMed Web of Science ®Google Scholar
• Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354(1):11–22.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354(1):23–33.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Conclusions and recommendations from the immunization strategic advisory group. Wkly Epidemiol Rec. 2006;81(1):2–11.
   Google Scholar
• Burnett E, Yen C, Tate JE, et al. Rotavirus vaccines: current global impact and future perspectives. Future Virol. 2016;11(10):699–708.
   PubMed Web of Science ®Google Scholar
• Desai R, Oliveira LH, Parashar UD, et al. Reduction in morbidity and mortality from childhood diarrhoeal disease after species A rotavirus vaccine introduction in Latin America - a review. Mem Inst Oswaldo Cruz. 2011;106(8):907–911.
   PubMed Web of Science ®Google Scholar
• Salinas B, Pérez Schael I, Linhares AC, et al. Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: a randomized, placebo-controlled trial in Latin American infants. Pediatr Infect Dis J. 2005;24(9):807–816.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Clark HF, Offit PA, et al. Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants. Vaccine. 2006;24(22):4821–4829.
   PubMed Web of Science ®Google Scholar
• Araujo EC, Clemens SA, Oliveira CS, et al. Safety, immunogenicity, and protective efficacy of two doses of RIX4414 live attenuated human rotavirus vaccine in healthy infants. J Pediatr (Rio J). 2007;83(3):217–224.
   PubMed Web of Science ®Google Scholar
• Goveia MG, Rodriguez ZM, Dallas MJ, et al. Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants. Pediatr Infect Dis J. 2007;26(12):1099–1104.
   PubMed Web of Science ®Google Scholar
• Perez-Schael I, Salinas B, Tomat M, et al. Efficacy of the human rotavirus vaccine RIX4414 in malnourished children. J Infect Dis. 2007;196(4):537–540.
   PubMed Web of Science ®Google Scholar
• Ruiz-Palacios GM, Guerrero ML, Bautista-Márquez A, et al. Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants. Pediatrics. 2007;120(2):e253–261.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Itzler R, Matson DO, et al. Efficacy of a pentavalent rotavirus vaccine in reducing rotavirus-associated health care utilization across three regions (11 countries). Int J Infect Dis. 2007;11(Suppl 2):S29–35.
   PubMedGoogle Scholar
• Goveia MG, DiNubile MJ, Dallas MJ, et al. Efficacy of pentavalent human-bovine (WC3) reassortant rotavirus vaccine based on breastfeeding frequency. Pediatr Infect Dis J. 2008;27(7):656–658.
   PubMed Web of Science ®Google Scholar
• Linhares AC, Velázquez FR, Pérez-Schael I, et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet. 2008;371(9619):1181–1189.
   PubMed Web of Science ®Google Scholar
• Santos VS, Marques DP, Martins-Filho PR, et al. Effectiveness of rotavirus vaccines against rotavirus infection and hospitalization in Latin America: systematic review and meta-analysis. Infect Dis Poverty. 2016;5(1):83.
   PubMedGoogle Scholar
• Velázquez RF, Linhares AC, Muñoz S, et al. Efficacy, safety and effectiveness of licensed rotavirus vaccines: a systematic review and meta-analysis for Latin America and the Caribbean. BMC Pediatr. 2017;17(1):14.
   PubMed Web of Science ®Google Scholar
• de Oliveira LH, Camacho LA, Coutinho ES, et al. Rotavirus vaccine effectiveness in Latin American and Caribbean countries: a systematic review and meta-analysis. Vaccine. 2015;33(Suppl 1):A248–254.
   PubMedGoogle Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
   PubMed Web of Science ®Google Scholar
• Pindyck T, Tate JE, Parashar UD. A decade of experience with rotavirus vaccination in the United States - vaccine uptake, effectiveness, and impact. Expert Rev Vaccines. 2018;17(7):593–606.
   PubMed Web of Science ®Google Scholar
• Under five mortality: current status and progress [Internet]. New York, NY: UNICEF; 2017. [cited 2018 Jul 27]. Available from: https://data.unicef.org/topic/child-survival/under-five-mortality/
   Google Scholar
• Immunization, vaccines, and biologicals: data, statistics, and graphics [Internet]. Geneva: World Health Organization; 2017. [cited 2018 Jul 27]. Available from: http://www.who.int/immunization/monitoring_surveillance/data/en/
   Google Scholar
• Jonesteller CL, Burnett E, Yen C, et al. Effectiveness of rotavirus vaccination: a systematic review of the first decade of global postlicensure data, 2006–2016. Clin Infect Dis. 2017;65(5):840–850.
   PubMed Web of Science ®Google Scholar
• Shah MP, Tate JE, Mwenda JM, et al. Estimated reductions in hospitalizations and deaths from childhood diarrhea following implementation of rotavirus vaccination in Africa. Expert Rev Vaccines. 2017;16(10):987–995.
   PubMed Web of Science ®Google Scholar
• Burnett E, Tate JE, Kirkwood CD, et al. Estimated impact of rotavirus vaccine on hospitalizations and deaths from rotavirus diarrhea among children <5 in Asia. Expert Rev Vaccines. 2018;17(5):453–460.
   PubMed Web of Science ®Google Scholar
• United Nations Population Division. World population prospects: the 2017 revision. New York, NY: United Nations; 2017. [cited 2018 Jul 27]. Available from: https://esa.un.org/unpd/wpp/
   Google Scholar
• Child rotavirus deaths by country, 2000–2013 [Internet]. Geneva: World Health Organization; 2016. [cited 2018 Jul 27]. Available from: http://www.who.int/immunization/monitoring_surveillance/rotavirus_deaths_by_country_2000-2013.xlsx?ua=1
   Google Scholar
• Correia JB, Patel MM, Nakagomi O, et al. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil. J Infect Dis. 2010;201(3):363–369.
   PubMed Web of Science ®Google Scholar
• Cotes-Cantillo K, Paternina-Caicedo A, Coronell-Rodríguez W, et al. Effectiveness of the monovalent rotavirus vaccine in Colombia: a case-control study. Vaccine. 2014;32(25):3035–3040.
   PubMed Web of Science ®Google Scholar
• de Palma O, Cruz L, Ramos H, et al. Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study. BMJ. 2010;340:c2825.
   PubMed Web of Science ®Google Scholar
• Justino MC, Linhares AC, Lanzieri TM, et al. Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Belém, Brazil. Pediatr Infect Dis J. 2011;30(5):396–401.
   PubMed Web of Science ®Google Scholar
• Patel MM, Patzi M, Pastor D, et al. Effectiveness of monovalent rotavirus vaccine in Bolivia: case-control study. BMJ. 2013;346:f3726.
   PubMed Web of Science ®Google Scholar
• Pringle KD, Patzi M, Tate JE, et al. Sustained effectiveness of rotavirus vaccine against very severe rotavirus disease through the second year of life, Bolivia 2013–2014. Clin Infect Dis. 2016;62(Suppl 2):S115–S120.
   PubMedGoogle Scholar
• Patel M, Pedreira C, De Oliveira LH, et al. Duration of protection of pentavalent rotavirus vaccination in Nicaragua. Pediatrics. 2012;130(2):e365–e372.
   PubMed Web of Science ®Google Scholar
• Cotes K, Alvis-Guzmán N, Rico A, et al. [Impact assessment of the rotavirus vaccine in Colombia using rapid evaluation methods]. Rev Panam Salud Publica. 2013;34(4):220–226. Spanish.
   PubMed Web of Science ®Google Scholar
• Ichihara MY, Rodrigues LC, Teles Santos CA, et al. Effectiveness of rotavirus vaccine against hospitalized rotavirus diarrhea: a case-control study. Vaccine. 2014;32(23):2740–2747.
   PubMed Web of Science ®Google Scholar
• Patel M, Pedreira C, De Oliveira LH, et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA. 2009;301(21):2243–2251.
   PubMed Web of Science ®Google Scholar
• Mast TC, Khawaja S, Espinoza F, et al. Case-control study of the effectiveness of vaccination with pentavalent rotavirus vaccine in Nicaragua. Pediatr Infect Dis J. 2011;30(11):e209–e215.
   PubMed Web of Science ®Google Scholar
• Patel M, Pedreira C, De Oliveira LH, et al. Effectiveness of pentavalent rotavirus vaccine against a diverse range of circulating strains in Nicaragua. Clin Infect Dis. 2016;62(Suppl 2):S127–S132.
   PubMedGoogle Scholar
• Assis AS, Valle DA, Antunes GR, et al. Rotavirus epidemiology before and after vaccine introduction. J Pediatr (Rio J). 2013;89(5):470–476.
   PubMed Web of Science ®Google Scholar
• Sáfadi MA, Berezin EN, Munford V, et al. Hospital-based surveillance to evaluate the impact of rotavirus vaccination in São Paulo, Brazil. Pediatr Infect Dis J. 2010;29(11):1019–1022.
   PubMed Web of Science ®Google Scholar
• Pérez J, Zdenka L, Suárez Barrientos E. Enteritis por rotavirus durante la temporada rotavírica Marzo–julio antes y después de la implementación de la vacuna rotarix Centro Pediátrico Albina Patiño (CPAP) [Rotavirus enteritis during the March–July rotavirus season before and after the implementation of the Rotarix Albina Patiño Pediatric Center (CPAP) vaccine]. Gac Méd Bol. 2010;33(1):5–11.
   Google Scholar
• Montenegro FM, Falbo AR, Germano EM, et al. Reduction in rotavirus disease and sustained predominance of g2p[4] rotavirus strain following introduction of rotavirus vaccine in Recife, Brazil. J Trop Pediatr. 2015;61(3):206–209.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Progress in the introduction of rotavirus vaccine—Latin America and the Caribbean, 2006–2010. MMWR Morb Mortal Wkly Rep. 2011;60(47):1611–1614.
   PubMedGoogle Scholar
• Yen C, Armero Guardado JA, Alberto P, et al. Decline in rotavirus hospitalizations and health care visits for childhood diarrhea following rotavirus vaccination in El Salvador. Pediatr Infect Dis J. 2011;30(1 Suppl):S6–S10.
   PubMed Web of Science ®Google Scholar
• Inchauste L, Patzi M, Halvorsen K, et al. Impact of rotavirus vaccination on child mortality, morbidity, and rotavirus-related hospitalizations in Bolivia. Int J Infect Dis. 2017;61:79–88.
   PubMed Web of Science ®Google Scholar
• Costa I, Linhares AC, Cunha MH, et al. Sustained decrease in gastroenteritis-related deaths and hospitalizations in children less than 5 years of age after the introduction of rotavirus vaccination: a time-trend analysis in Brazil (2001–2010). Pediatr Infect Dis J. 2016;35(6):e180–e190.
   PubMed Web of Science ®Google Scholar
• Fernandes EG, Sato HK, Leshem E, et al. Impact of rotavirus vaccination on diarrhea-related hospitalizations in São Paulo State, Brazil. Vaccine. 2014;32(27):3402–3408.
   PubMed Web of Science ®Google Scholar
• Gurgel RQ, Ilozue C, Correia JB, et al. Impact of rotavirus vaccination on diarrhoea mortality and hospital admissions in Brazil. Trop Med Int Health. 2011;16(9):1180–1184.
   PubMed Web of Science ®Google Scholar
• Lanzieri TM, Costa I, Shafi FA, et al. Trends in hospitalizations from all-cause gastroenteritis in children younger than 5 years of age in Brazil before and after human rotavirus vaccine introduction, 1998–2007. Pediatr Infect Dis J. 2010;29(7):673–675.
   PubMed Web of Science ®Google Scholar
• Quintanar-Solares M, Yen C, Richardson V, et al. Impact of rotavirus vaccination on diarrhea-related hospitalizations among children < 5 years of age in Mexico. Pediatr Infect Dis J. 2011;30(1 Suppl):S11–S15.
   PubMed Web of Science ®Google Scholar
• Sánchez-Uribe E, Esparza-Aguilar M, Parashar UD, et al. Sustained reduction of childhood diarrhea-related mortality and hospitalizations in Mexico after rotavirus vaccine universalization. Clin Infect Dis. 2016;62(Suppl 2):S133–S139.
   PubMed Web of Science ®Google Scholar
• Boccolini CS, Boccolini Pde M, de Carvalho ML, et al. Exclusive breastfeeding and diarrhea hospitalization patterns between 1999 and 2008 in Brazilian State Capitals. Cien Saude Colet. 2012;17(7):1857–1863. Portuguese.
   PubMed Web of Science ®Google Scholar
• Orozco M, Vasquez J, Pedreira C, et al. Uptake of rotavirus vaccine and national trends of acute gastroenteritis among children in Nicaragua. J Infect Dis. 2009;200(Suppl 1):S125–130.
   PubMedGoogle Scholar
• Bayard V, DeAntonio R, Contreras R, et al. Impact of rotavirus vaccination on childhood gastroenteritis-related mortality and hospital discharges in Panama. Int J Infect Dis. 2012;16(2):e94–e98.
   PubMed Web of Science ®Google Scholar
• Molto Y, Cortes JE, De Oliveira LH, et al. Reduction of diarrhea-associated hospitalizations among children aged < 5 years in Panama following the introduction of rotavirus vaccine. Pediatr Infect Dis J. 2011;30(1 Suppl):S16–S20.
   PubMed Web of Science ®Google Scholar
• Nieto Guevara J, López O, González G. Impact of rotavirus vaccine introduction on hospital admissions for severe acute gastroenteritis at the Children’s Hospital in Panama City. Rev Panam Salud Publica. 2008;24(3): 189–194. Portuguese.
   PubMed Web of Science ®Google Scholar
• Gurgel RQ, Alvarez Ade J, Rodrigues A, et al. Incidence of rotavirus and circulating genotypes in Northeast Brazil during 7 years of national rotavirus vaccination. PLoS One. 2014;9(10):e110217.
   PubMed Web of Science ®Google Scholar
• Paulo RL, Rodrigues AB, Machado BM, et al. The impact of rotavirus vaccination on emergency department visits and hospital admissions for acute diarrhea in children under 5 years. Rev Assoc Med Bras. 1992 [2016];62(6):506–512.
   Google Scholar
• Esparza-Aguilar M, Gastañaduy PA, Sánchez-Uribe E, et al. Diarrhoea-related hospitalizations in children before and after implementation of monovalent rotavirus vaccination in Mexico. Bull World Health Organ. 2014;92(2):117–125.
   PubMed Web of Science ®Google Scholar
• Do Carmo GM, Yen C, Cortes J, et al. Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis. PLoS Med. 2011;8(4):e1001024.
   PubMed Web of Science ®Google Scholar
• Masukawa Mde L, Moriwaki AM, Uchimura NS, et al. Intervention analysis of introduction of rotavirus vaccine on hospital admissions rates due to acute diarrhea. Cad Saude Publica. 2014;30(10):2101–2111.
   PubMed Web of Science ®Google Scholar
• Masukawa MD, Moriwaki AM, Santana RG, et al. Impact of oral human rotavirus vaccine on hospitalization rates for children. Acta Paul Enferm. 2015;28(3):243–249.
   Web of Science ®Google Scholar
• Masukawa ML, Souza EM, Gimenes E, et al. Time series investigation of changes in seasonality of acute diarrhea hospitalizations before and after rotavirus vaccine in Southern Brazil. Cad Saude Publica. 2016;32(10):e00080515.
   PubMed Web of Science ®Google Scholar
• Lanzieri TM, Linhares AC, Costa I, et al. Impact of rotavirus vaccination on childhood deaths from diarrhea in Brazil. Int J Infect Dis. 2011;15(3):e206–e210.
   PubMed Web of Science ®Google Scholar
• Gastañaduy PA, Sánchez-Uribe E, Esparza-Aguilar M, et al. Effect of rotavirus vaccine on diarrhea mortality in different socioeconomic regions of Mexico. Pediatrics. 2013;131(4):e1115–e1120.
   PubMed Web of Science ®Google Scholar
• Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med. 2010 28;362(4):299–305.
   PubMed Web of Science ®Google Scholar
• Paternina-Caicedo A, Parashar UD, Alvis-Guzmán N, et al. Effect of rotavirus vaccine on childhood diarrhea mortality in five Latin American countries. Vaccine. 2015;33(32):3923–3928.
   PubMed Web of Science ®Google Scholar
• Franco-Soto V, Rísquez-Parra A, Colmenares R, et al. Impacto de la vacunación contra el rotavirus sobre la morbilidad y mortalidad en diarreas [Impact of rotavirus vaccination on morbidity and mortality in diarrhea]. Arch Venez Pueric Pediatr. 2013;76(3):93–98.
   Google Scholar
• Rísquez-Parra A, Rosales-López T, Rosas MA. Observación inicial del impacto de la vacuna antirotavirus sobre la morbi-mortalidad por diarreas en Venezuela 2002–2010 [Initial observation of the impact of the antirotavirus vaccine on diarrheal morbidity and mortality in Venezuela 2002–2010]. Bol Venez Infectol. 2012;23(1):26–32.
   Google Scholar
• Amador JJ, Vasquez J, Orozco M, et al. Rotavirus disease burden, Nicaragua 2001–2005: defining the potential impact of a rotavirus vaccination program. Int J Infect Dis. 2010;14(7):e592–e595.
   PubMed Web of Science ®Google Scholar
• Cáceres DC, Peláez D, Sierra N, et al. Burden of rotavirus-related disease among children under five, Colombia, 2004. Rev Panam Salud Publica. 2006;20(1):9–21. Spanish.
   PubMed Web of Science ®Google Scholar
• Cortes J, Arvelo W, Lopez B, et al. Rotavirus disease burden among children <5 years of age—Santa Rosa, Guatemala, 2007–2009. Trop Med Int Health. 2012;17(2):254–259.
   PubMed Web of Science ®Google Scholar
• Guardado JA, Clará WAW, Turcios RM, et al. Rotavirus in El Salvador: an outbreak, surveillance and estimates of disease burden, 2000–2002. Pediatr Infect Dis J. 2004;23(10 Suppl):S156–S160.
   PubMedGoogle Scholar
• Rheingans RD, Constenla D, Antil L, et al. Economic and health burden of rotavirus gastroenteritis for the 2003 birth cohort in eight Latin American and Caribbean countries. Rev Panam Salud Publica. 2007;21(4):192–204.
   PubMed Web of Science ®Google Scholar
• Solórzano Girón JO, Molina IB, Turcios-Ruiz RM, et al. Burden of diarrhea among children in Honduras, 2000–2004: estimates of the role of rotavirus. Rev Panam Salud Publica. 2006;20(6):377–384.
   PubMed Web of Science ®Google Scholar
• DeAntonio R, Amador S, Bunge EM, et al. Vaccination herd effect experience in Latin America: a systematic literature review. Hum Vaccin Immunother. 2018;1–23.
   Google Scholar